Is There a High-Risk Subgroup of Stage I Epithelial Ovarian Cancer That Is Most Likely to Benefit From 6 Versus 3 Cycles of Adjuvant Chemotherapy?

Title
Is There a High-Risk Subgroup of Stage I Epithelial Ovarian Cancer That Is Most Likely to Benefit From 6 Versus 3 Cycles of Adjuvant Chemotherapy?
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
Volume 20, Issue 7, Pages 1125-1131
Publisher
Wiley
Online
2010-12-04
DOI
10.1111/igc.0b013e3181efd843

Ask authors/readers for more resources

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now